Yayın: Type 2 dynamic curves: A diagnostic dilemma
| dc.contributor.author | Karavas, Erdal | |
| dc.contributor.author | Ece, Bunyamin | |
| dc.contributor.author | Aydın, Sonay | |
| dc.date.accessioned | 2026-01-04T17:05:00Z | |
| dc.date.issued | 2022-07-28 | |
| dc.description.abstract | Magnetic resonance imaging (MRI) with multiparametric dynamic contrast plays a critical role in the assessment of breast lesions. Dynamic curves are a critical parameter in determining the benign or malignant nature of lesions. Dynamic curves of type 1 are known to represent benign masses, while dynamic curves of type 3 are known to identify malignant masses. Type 2 dynamic curves have a sensitivity of 42.6% and specificity of 75% for malignancy detection.To investigate the pathological diagnosis of lesions with type 2 dynamic curves.We evaluated breast MRI examinations performed between 2020 and 2021 retrospectively and included lesions with type 2 dynamic curves. We included 38 lesions from 33 patients. The lesions were evaluated for their pathological diagnosis and morphological characteristics.Twenty-six lesions were malignant, while twelve were benign. The most frequently encountered benign lesion (7/12, 58.3%) was sclerosing adenosis, while the most frequently encountered malignant diagnosis was invasive ductal cancer. The presence of a type 2 dynamic curve had a sensitivity of 40.2% and specificity of 73.4% for predicting malignancy. By combining type 2 curves and morphological features, the sensitivity and specificity were increased.The high rates of malignancy detected histopathologically among patients with type 2 dynamic curves in our study are remarkable. Type 2 dynamic curves can be detected in benign breast masses, especially in sclerosing adenosis cases. Considering morphological features can increase the diagnostic accuracy in cases with type 2 dynamic curves. | |
| dc.description.uri | https://doi.org/10.4329/wjr.v14.i7.229 | |
| dc.description.uri | https://pubmed.ncbi.nlm.nih.gov/36160627 | |
| dc.description.uri | http://dx.doi.org/10.4329/wjr.v14.i7.229 | |
| dc.identifier.doi | 10.4329/wjr.v14.i7.229 | |
| dc.identifier.endpage | 237 | |
| dc.identifier.issn | 1949-8470 | |
| dc.identifier.openaire | doi_dedup___::3968cbf4fc7e1d89ed7aad85fbe680e0 | |
| dc.identifier.orcid | 0000-0001-6649-3256 | |
| dc.identifier.orcid | 0000-0001-6288-8410 | |
| dc.identifier.pubmed | 36160627 | |
| dc.identifier.startpage | 229 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12597/39883 | |
| dc.identifier.volume | 14 | |
| dc.identifier.wos | 000837255000005 | |
| dc.publisher | Baishideng Publishing Group Inc. | |
| dc.relation.ispartof | World Journal of Radiology | |
| dc.rights | OPEN | |
| dc.subject | Retrospective Study | |
| dc.subject.sdg | 3. Good health | |
| dc.title | Type 2 dynamic curves: A diagnostic dilemma | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.api.response | {"authors":[{"fullName":"Karavas, Erdal","name":"Erdal","surname":"Karavas","rank":1,"pid":{"id":{"scheme":"orcid","value":"0000-0001-6649-3256"},"provenance":null}},{"fullName":"Ece, Bunyamin","name":"Bunyamin","surname":"Ece","rank":2,"pid":{"id":{"scheme":"orcid","value":"0000-0001-6288-8410"},"provenance":null}},{"fullName":"Aydın, Sonay","name":"Sonay","surname":"Aydın","rank":3,"pid":null}],"openAccessColor":"gold","publiclyFunded":false,"type":"publication","language":{"code":"und","label":"Undetermined"},"countries":null,"subjects":[{"subject":{"scheme":"FOS","value":"03 medical and health sciences"},"provenance":null},{"subject":{"scheme":"FOS","value":"0302 clinical medicine"},"provenance":null},{"subject":{"scheme":"keyword","value":"Retrospective Study"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null}],"mainTitle":"Type 2 dynamic curves: A diagnostic dilemma","subTitle":null,"descriptions":["Magnetic resonance imaging (MRI) with multiparametric dynamic contrast plays a critical role in the assessment of breast lesions. Dynamic curves are a critical parameter in determining the benign or malignant nature of lesions. Dynamic curves of type 1 are known to represent benign masses, while dynamic curves of type 3 are known to identify malignant masses. Type 2 dynamic curves have a sensitivity of 42.6% and specificity of 75% for malignancy detection.To investigate the pathological diagnosis of lesions with type 2 dynamic curves.We evaluated breast MRI examinations performed between 2020 and 2021 retrospectively and included lesions with type 2 dynamic curves. We included 38 lesions from 33 patients. The lesions were evaluated for their pathological diagnosis and morphological characteristics.Twenty-six lesions were malignant, while twelve were benign. The most frequently encountered benign lesion (7/12, 58.3%) was sclerosing adenosis, while the most frequently encountered malignant diagnosis was invasive ductal cancer. The presence of a type 2 dynamic curve had a sensitivity of 40.2% and specificity of 73.4% for predicting malignancy. By combining type 2 curves and morphological features, the sensitivity and specificity were increased.The high rates of malignancy detected histopathologically among patients with type 2 dynamic curves in our study are remarkable. Type 2 dynamic curves can be detected in benign breast masses, especially in sclerosing adenosis cases. Considering morphological features can increase the diagnostic accuracy in cases with type 2 dynamic curves."],"publicationDate":"2022-07-28","publisher":"Baishideng Publishing Group Inc.","embargoEndDate":null,"sources":["Crossref","World J Radiol"],"formats":null,"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_abf2","label":"OPEN","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"World Journal of Radiology","issnPrinted":"1949-8470","issnOnline":null,"issnLinking":null,"ep":"237","iss":null,"sp":"229","vol":"14","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::3968cbf4fc7e1d89ed7aad85fbe680e0","originalIds":["10.4329/wjr.v14.i7.229","50|doiboost____|3968cbf4fc7e1d89ed7aad85fbe680e0","od_______267::b03244d4634a875ea9cbf206e6e616bd","36160627","PMC9350610","oai:pubmedcentral.nih.gov:9350610","50|od_______267::b03244d4634a875ea9cbf206e6e616bd"],"pids":[{"scheme":"doi","value":"10.4329/wjr.v14.i7.229"},{"scheme":"pmid","value":"36160627"},{"scheme":"pmc","value":"PMC9350610"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":2,"influence":2.6106097e-9,"popularity":3.399238e-9,"impulse":2,"citationClass":"C5","influenceClass":"C5","impulseClass":"C5","popularityClass":"C5"}},"instances":[{"pids":[{"scheme":"doi","value":"10.4329/wjr.v14.i7.229"}],"type":"Article","urls":["https://doi.org/10.4329/wjr.v14.i7.229"],"publicationDate":"2022-07-28","refereed":"peerReviewed"},{"pids":[{"scheme":"pmid","value":"36160627"},{"scheme":"pmc","value":"PMC9350610"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.4329/wjr.v14.i7.229"}],"type":"Article","urls":["https://pubmed.ncbi.nlm.nih.gov/36160627"],"refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.4329/wjr.v14.i7.229"}],"license":"CC BY NC","type":"Other literature type","urls":["http://dx.doi.org/10.4329/wjr.v14.i7.229"],"publicationDate":"2022-07-28","refereed":"nonPeerReviewed"}],"isGreen":true,"isInDiamondJournal":false} | |
| local.import.source | OpenAire | |
| local.indexed.at | WOS | |
| local.indexed.at | PubMed |
